{"date":"2026-09-29","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-09-29-1810-r260jh","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-29","time":"18:10:34","subject":"代重要子公司Belite Bio, Inc公告受邀參加歐洲視網膜專家學會2026年會(Euretina 2026)","clause":"第44款","fact_date":"2026-10-04","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-29 18:10，「代重要子公司Belite Bio, Inc公告受邀參加歐洲視網膜專家學會2026年會(Euretina 2026)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-09-29-1807-1ep7po6","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-09-29","time":"18:07:27","subject":"代重要子公司Belite Bio, Inc公告受邀參加Euretina創新聚焦會議(EIS)","clause":"第44款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-09-29 18:07，「代重要子公司Belite Bio, Inc公告受邀參加Euretina創新聚焦會議(EIS)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-09-29-1735-1wxzb4f","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-09-29","time":"17:35:27","subject":"公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日","clause":"第53款","fact_date":"2026-09-29","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-09-29 17:35，「公告本公司董事長依董事會授權訂定員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-09-29-1657-hlxb99","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-09-29","time":"16:57:32","subject":"公告本公司內部稽核主管任命案","clause":"第8款","fact_date":"2026-09-29","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-09-29 16:57，「公告本公司內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-09-29-1657-1f13hw2","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-09-29","time":"16:57:16","subject":"公告本公司113年度現金增資資金運用計畫變更及預計效益變更","clause":"第16款","fact_date":"2026-09-29","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-09-29 16:57，「公告本公司113年度現金增資資金運用計畫變更及預計效益變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-09-29-1620-qkrt5g","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-09-29","time":"16:20:01","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"第44款","fact_date":"2026-09-29","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-09-29 16:20，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-09-29-1601-621epg","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-09-29","time":"16:01:25","subject":"本公司受邀參加國票證券舉辦之實體座談會","clause":"第12款","fact_date":"2026-09-30","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-09-29 16:01，「本公司受邀參加國票證券舉辦之實體座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-09-29-1542-1h3ceio","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-09-29","time":"15:42:01","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2026-09-29","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-09-29 15:42，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-09-29-0031-1t4smi4","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-09-29","time":"00:31:36","subject":"代重要子公司安立璽榮生醫股份有限公司公告，用於治療阿茲海默症之新藥EI-1071，獲台灣衛生福利部食品藥物管理署(TFDA)核准執行食物影響第一期臨床試驗","clause":"第8款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-09-29 00:31，「代重要子公司安立璽榮生醫股份有限公司公告，用於治療阿茲海默症之新藥EI-1071，獲台灣衛生福利部食品藥物管理署(TFD」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}